CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
09 déc. 2023 00h00 HE
|
CURE Media Group
CRANBURY, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to more than 1 million patients,...
CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition program
16 nov. 2023 10h38 HE
|
CURE Media Group
CURE and Incyte Corporation are proud to host the 2023 MPN Heroes recognition ceremony, an evening of gratitude and celebration of the heroes who have made a significant impact in the lives of...
CURE Media Group announces winners of the 2022 MPN Heroes Recognition Program
09 déc. 2022 11h00 HE
|
CURE Media Group
CRANBURY, N.J., Dec. 09, 2022 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to the more than one million patients,...
CURE Media Group announces Vanessa Bayer as keynote speaker for the 2022 MPN Heroes® Recognition Program
02 déc. 2022 17h41 HE
|
CURE Media Group
CRANBURY, N.J., Dec. 02, 2022 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to the more than one million patients,...
Inaugural Sole 2 Soul for MPN™ Trek Set For August 3-7, 2022 in Waterton Lakes National Park in Canada
03 août 2022 08h01 HE
|
CURE Media Group
CRANBURY, N.J., Aug. 03, 2022 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to cancer updates and research that reaches more than 1 million patients,...
Imago BioSciences Announces Completion of Enrollment in Phase 2 Clinical Study of Bomedemstat in Essential Thrombocythemia
03 mai 2022 08h00 HE
|
Imago Biosciences, Inc.
Interim Data Update at European Hematology Association (EHA) meeting in June and Results from Completed Phase 2 Study Expected in Second Half of 2022 End-of-Phase 2 Meeting with U.S. Food and...
Imago BioSciences to Host Virtual Investor Event
01 déc. 2021 08h00 HE
|
Imago Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. (“Imago” or the “Company”) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new...
Imago BioSciences to Present at Stifel 2021 Virtual Healthcare Conference
11 nov. 2021 16h05 HE
|
Imago Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the...
Imago BioSciences Reports Third Quarter 2021 Financial Results and Provides Recent Business Updates
10 nov. 2021 16h05 HE
|
Imago Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical-stage biopharmaceutical company discovering new medicines for the...